Overview
My PhD project focus on how a specific protein of the ECM (POSTN) modulate macrophages behavior in chemotherapy resistance in TNBC. Similarly, I am interested in studying the influence of glycans in the ECM on macrophages and T cells in the TME.
Related News
‘Sugar-coated’ tumour matrix may offer way to make triple-negative breast cancer easier to treat
Researchers at Barts Cancer Institute, Queen Mary University of London, have discovered a way in which the environment surrounding triple-negative breast cancer cells helps suppress our immune system, making this cancer harder to treat. The findings open the door to a potential new treatment strategy that could make triple-negative breast cancers more vulnerable to the immune system and help more people to benefit from immunotherapy in future.
Publications 18 June 2026